Skip to main content
Signal8
Mifek Jeffrey Gerald profile photo

Jeffrey Gerald Mifek

CIK: 0002143295

Transaction Breakdown

Open Market Buys (P)1 (25.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (75.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FEMASYS INC logo
FEMY

FEMASYS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • FEMASYS INC logo
    FEMY

    FEMASYS INC

    Aug 7, 2026
    Purchase(P)
    Direct
    3.1K shares at avg. $3.20$10K
  • FEMASYS INC logo
    FEMY

    FEMASYS INC

    Aug 7, 2026
    Award(A)

    Common Stock Purchase Warrant

    Direct
    3.1K shares-
  • FEMASYS INC logo
    FEMY

    FEMASYS INC

    Aug 7, 2026
    Award(A)

    Common Stock Purchase Warrant (Milestone)

    Direct
    3.1K shares-
  • FEMASYS INC logo
    FEMY

    FEMASYS INC

    Jul 6, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    6.3K shares-

1-4 of 4

About Mifek Jeffrey Gerald

Mifek Jeffrey Gerald (SEC CIK 0002143295) files insider reports with the SEC as Chief Clinical-Medical Affairs of FEMASYS INC (FEMY).

Signal8 holds 3 ownership filings by Mifek Jeffrey Gerald (1 Form 3, 2 Form 4), filed on Aug 11, 2026. Those filings report 4 transactions, from Jul 6, 2026 to Aug 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Mifek Jeffrey Gerald's filings is in SUWANEE, GA.

Recent filings by Mifek Jeffrey Gerald

  • Aug 7, 2026: Open-market purchase of FEMY shares (Form 4, code P).
  • Aug 7, 2026: Grants or awards of FEMY derivative securities (2 lines, Form 4, code A).
  • Jul 6, 2026: Grant or award of FEMY derivative securities (Form 4, code A).

Other insiders filing for FEMASYS INC (FEMY)

How to read Form 4 transaction codes